Ellingson Rachel
SEC CIK 1557271 · EDGAR
Most active insiders at BLFS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners Master Fund, L.P. | 10% | — | $28.12M |
| 2 | Casdin Partners GP, LLC | 10% | — | $21.41M |
| 3 | DE GREEF RODERICK | Pres, CEO, Dir | — | $3.61M |
| 4 | Foster Karen A. | Chief Quality, Ops | — | $2.07M |
| 5 | Wichterman Troy | CFO | — | $873.5K |
| 6 | DuRoss Amy | Dir | — | $305.7K |
| 7 | Mathew Aby J. | EVP, CSO | — | $65.2K |
| 8 | GOSWAMI JOYDEEP | Dir | — | $48.3K |
| 9 | Aebersold Sarah | CHRO | — | $45.0K |
| 10 | Berard Todd | CMO | — | $42.4K |
| 15 | Ellingson Rachel | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +8,170 | 58.0K | +16% | — | |
| 2025-03-20 | 2025-03-18 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +6,876 | 49.8K | +16% | — | |
| D | 2025-02-24 | 2025-02-20 | ZBH | Zimmer Biomet | Ellingson Rachel | Chief Administrative Off | M - OptEx | $0.00 | +1,566 | 12.4K | +14% | $0 |
| D | 2025-02-24 | 2025-02-20 | ZBH | Zimmer Biomet | Ellingson Rachel | Chief Administrative Off | F - Tax | $103.46 | -491 | 11.9K | -4% | -$50.8K |
| D | 2025-02-19 | 2025-02-18 | ZBH | Zimmer Biomet | Ellingson Rachel | Chief Administrative Off | M - OptEx | $0.00 | +5,572 | 12.6K | +79% | $0 |
| D | 2025-02-19 | 2025-02-18 | ZBH | Zimmer Biomet | Ellingson Rachel | Chief Administrative Off | F - Tax | $101.00 | -1,792 | 10.8K | -14% | -$181.0K |
| 2024-03-12 | 2024-03-08 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +11.3K | 42.9K | +36% | — | |
| D | 2024-03-08 | 2024-03-06 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | F - Tax | $125.82 | -445 | 6,846 | -6% | -$56.0K |
| D | 2024-03-08 | 2024-03-06 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | M - OptEx | $0.00 | +1,419 | 7,291 | +24% | $0 |
| D | 2024-02-27 | 2024-02-25 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | F - Tax | $128.80 | -588 | 5,872 | -9% | -$75.7K |
| D | 2024-02-27 | 2024-02-25 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | M - OptEx | $0.00 | +1,762 | 6,460 | +38% | $0 |
| 2023-11-03 | 2023-11-01 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +495 | 31.7K | +2% | — | |
| 2023-10-10 | 2023-10-01 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +362 | 31.2K | +1% | — | |
| D | 2023-02-23 | 2023-02-21 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | M - OptEx | $0.00 | +1,046 | 4,864 | +27% | $0 |
| D | 2023-02-23 | 2023-02-21 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | F - Tax | $124.73 | -361 | 4,503 | -7% | -$45.0K |
| 2023-01-18 | 2023-01-03 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +10.2K | 30.8K | +49% | — | |
| 2022-08-02 | 2022-08-01 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +259 | 20.6K | +1% | — | |
| 2022-07-06 | 2022-07-01 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +341 | 20.4K | +2% | — | |
| 2022-06-03 | 2022-06-01 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +311 | 20.0K | +2% | — | |
| 2022-05-10 | 2022-05-06 | BLFS | BIOLIFE SOLUTIONS INC | Ellingson Rachel | Dir | A - Grant | — | +14.7K | 19.7K | +295% | — | |
| D | 2022-05-03 | 2022-05-01 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | M - OptEx | $0.00 | +531 | 3,791 | +16% | $0 |
| D | 2022-05-03 | 2022-05-01 | ZBH | Zimmer Biomet | Ellingson Rachel | SVP, Chief Strategy Off | F - Tax | $122.43 | -167 | 3,624 | -4% | -$20.4K |
Purchase Sale Sale after option exercise All abbreviations